Skip to main content
. 2022 Apr 8;10:93. doi: 10.1186/s40359-022-00797-6

Table 1.

Participant demographic and medical information

Variable Post-surgical resection, n (%) Watchful waiting, n (%)
Count 14 (46.67) 16 (53.33)
Age (years)
 Range 39–80 33–84
 Mx (Sx) 55.71 (10.59) 56.31 (14.35)
Gender
 Men 5 (35.71) 5 (31.25)
 Women 9 (64.29) 11 (68.75)
Tumour grade
 WHO Grade I 11 (78.57)
 WHO Grade II 3 (21.43)
Extent of tumour resection
 Total 12 (85.71)
 Subtotal 2 (14.29)
Tumour lateralization
 Right 6 (42.86) 11 (68.75)
 Left 5 (35.71) 3 (18.75)
 Other (bilateral, unspecified) 3 (21.43) 2 (12.50)
Tumour location
 Cerebellopontine Angle 0 (0) 2 (12.50)
 Convexity 3 (21.43) 2 (12.50)
 Falcine 3 (21.43) 3 (18.75)
 Foramen Magnum 1 (7.14) 0 (0)
 Olfactory Groove 1 (7.14) 2 (12.50)
 Parasagittal 0 (0) 1 (6.25)
 Posterior Fossa 1 (7.14) 2 (12.50)
 Sphenoidal 3 (21.43) 2 (12.50)
 Tentorial 1 (7.14) 2 (12.50)
 Other (bilateral, multiple) 1 (7.14) 2 (12.50)
History of radiation therapy
 Yes 3 (21.43) 2 (12.50)
 No 11 (78.57) 14 (87.50)
Presenting symptoms
 Headache 8 (57.14) 7 (43.75)
 Motor Deficit 8 (57.14) 3 (18.75)
 Seizure 3 (21.43) 1 (6.25)
 Vertigo/Dizziness/Unsteadiness 4 (28.57) 3 (18.75)
 Visual deficit 5 (35.71) 4 (25.00)
History of Neurological Risk Factor (HTN, DLD, Smoking)
 Yes 6 (42.86) 6 (37.50)
 No 8 (57.14) 10 (62.50)

Mx statistical mean, Sx standard deviation, HTN Hypertension, DLD Dyslipidemia